Develops, manufactures, and distributes immunodiagnostic test kits and research reagents

BioCheck specializes in the development and distribution of high-quality in vitro diagnostic products, including immunoassay devices, antibodies, and ELISA kits. Their offerings are rigorously tested to ensure they meet the highest standards of quality and specificity, making them suitable for various research and clinical applications. The company emphasizes the importance of value-based diagnostics, which focus on delivering effective and cost-efficient care through evidence-based diagnostic algorithms. This approach aims to improve patient outcomes while minimizing unnecessary testing and healthcare costs, thereby enhancing the overall efficiency of healthcare delivery.

In addition to their diagnostic products, BioCheck is involved in healthcare data monetization, which entails generating revenue through the sale or licensing of healthcare data. This data can provide valuable insights for various stakeholders in the healthcare industry, including pharmaceutical companies and research organizations. Furthermore, BioCheck promotes healthcare shared savings models that incentivize providers to reduce costs while maintaining or improving care quality. By aligning financial incentives and fostering collaboration among healthcare providers, BioCheck aims to enhance patient outcomes and drive innovation in the healthcare ecosystem.

United States

BioCheck develops and manufactures high-quality immunoassay kits for the worldwide healthcare markets in their cGMP and ISO 13485 certified facility in the San Francisco Bay Area. BioCheck also provides custom immunoassay development and contract manufacturing services to the diagnostic and research industries.

Biocheck

Company Details